- dott.ssa Marina Scavini
- dott.ssa Amelia Caretto, dott.ssa Alice Burini
The overall objective of the Diabetes Pregnancy Registry is to monitor and assess the safety of
Levemir® use in pregnant women with diabetes mellitus (DM), and to monitor their infants at 1 month and 1 year of age.
- Type 1 diabetes
- Single group
- N/A (not applicable)
An international non-interventional prospective cohort study to evaluate the safety of treatment with Levemir® (insulin detemir) in pregnant women with diabetes mellitus.